Table 3. Summary of testing data.
| Laboratory test type | Percent difference in TAT from normal vs. downtime operations |
|---|---|
| Amylase level a | 44.74% |
| Basic metabolic panel a | 38.50% |
| Beta HCG qualitative urine a | 15.88% |
| Complete blood count w/ differential a | 32.50% |
| Comprehensive metabolic panel a | 19.21% |
| Drug abuse screen urine | 41.46% |
| Lipase level a | 57.65% |
| Magnesium level a | 173.02% |
| Phosphorus level | 146.54% |
| PT and INR | −37.10% |
| PTT | −8.25% |
| Troponin-I a | 100.65% |
| Urinalysis IRIS complete | −37.28% |
| Urinalysis IRIS microscopic | −20.83% |
| Urinalysis IRIS reflex microscopic a | 10.99% |
Abbreviations: HCG, human chorionic gonadotropin; INR, international normalized ratio; PT, prothrombin time; PTT, partial thromboplastin time; TAT, turnaround time.
a
Significant delay.